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Background
One goal of supplementation has been to increase blood
flow to skeletal muscle during exercise. Raw L-citrulline
(RC) has often been used for its vasodilatory effects, and
recently, RC has been bound to a whey peptide (CP) to
increase bioavailability. The purpose of the present
study was to determine the acute hemodynamic effects of
RC, CP, and placebo (PLA) following resistance exercise in
healthy men when administered at a common, commercial
dose.
Methods
In a double-blind, crossover, placebo-controlled design,
11 recreationally-active males (28.2 ± 5.0y, 182.4 ± 5.7cm,
87.1 ± 10.3kg) ingested either 1.87 g of RC, 3.67 g of CP
(citrulline content 1.87 g), or a flavor-matched, visually
identical placebo (PLA) and performed 3 sets of 15 arm
curls at 30 and 120 minutes post-supplementation. Bra-
chial artery vessel diameter (VD) and blood flow volume
(BFV) were measured via Doppler ultrasound at 0, 3, and
6 minutes post-exercise, corresponding to 30 (30P), 33
(33P), 36 (36P), 120 (120P), 123 (123P), and 126 (126P)
minutes post-supplementation. Measurements were com-
pared with both resting baseline (no treatment, no exer-
cise) and active control (no treatment, exercise) values.
Raw data were analyzed for all group, time, and group ×
time interactions using 2-way repeated-measures
ANOVA. Delta values were analyzed using dependent
T-tests. Alpha was predetermined at p < 0.05.
Results
A significant (p < 0.05) group × time interaction was
present for VD, which increased in CP versus PLA from
resting baseline to 30P (CP: 0.58 ± 0.05; PLA: 0.55 ±
0.06cm) and 33P (CP: 0.57 ± 0.05; PLA: 0.54 ± 0.05cm).
VD also significantly (p < 0.05) increased in CP versus
PLA from active baseline to 30P, 33P, and 120P (CP:
0.58 ± 0.05; PLA: 0.55 ± 0.05cm). Moreover, CP signifi-
cantly (p < 0.05) increased VD versus RC at 30P (RC:
0.56 ± 0.06cm), 33P (RC: 0.55 ± 0.06cm), and 36P (CP:
0.55 ± 0.05; RC: 0.53 ± 0.06cm) compared to active
baselines. A significant (p < 0.05) group × time interac-
tion existed for BFV, which increased in CP versus PLA
from active baseline to 30P (CP: 686.3 ± 214.7; PLA:
554.8 ± 124.2mL/min). Additionally, significantly greater
delta values were observed for VD when comparing CP
and PLA at 30P, 33P, 36P, and 120P and for BFV at 30P
versus active ([CP VD 30P: +0.06 ± 0.03cm; 33P: +0.04
± 0.02; 36P: +0.03 ± 0.03cm], [PLA VD 30P: +0.02 ±
0.02; 33P: +0.02 ± 0.01; 36P: +0.01 ± 0.03cm], [CP BFV:
+198.0 ± 179.6; PLA BFV: +48.2 ± 104.1mL/min]) and
resting ([CP VD 30P: +0.10 ± 0.03cm; 33P: +0.08 ± 0.03;
36P: +0.07 ± 0.03cm], [PLA VD 30P: +0.06 ± 0.03; 33P:
+0.06 ± 0.02; 36P: +0.05 ± 0.02cm], [CP BFV: +608.9 ±
179.6; PLA BFV: +477.4 ± 130.0mL/min]) baselines. VD
and BFV delta values were significantly (p < 0.05) greater
for CP than RC at 30P, and VD changes remained
greater at 33P and 36P versus both active ([RC VD 30P:
+0.03 ± 0.02; 33P: +0.02 ± 0.02; 36P:+ 0.01 ± 0.02cm],
[RC BFV: +99.5 ± 152.2mL/min]) and resting ([RC VD
30P: +0.07 ± 0.04; 33P: +0.06 ± 0.04; 36P: +0.04 ±
0.04cm], [RC BFV: +510.5 ± 157.7mL/min]) baselines.* Correspondence: jordan.joy@musclepharm.com1MusclePharm Sports Science Institute, Denver, CO, USA
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Conclusions
Citrulline peptide can significantly increase vasodilation
and the volume of blood flow compared to raw citrulline
and placebo. Citrulline peptide may be a preferred choice
over raw citrulline for athletes seeking enhanced vasodila-
tion or blood flow.
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